These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7740055)

  • 21. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
    Evans SM; Funderburk FR; Griffiths RR
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1246-55. PubMed ID: 2262904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Residual effects of zolpidem, triazolam, rilmazafone and placebo in healthy elderly subjects: a randomized double-blind study.
    Uemura SI; Kanbayashi T; Wakasa M; Satake M; Ito W; Shimizu K; Shioya T; Shimizu T; Nishino S
    Sleep Med; 2015 Nov; 16(11):1395-1402. PubMed ID: 26498242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zaleplon and triazolam in humans: acute behavioral effects and abuse potential.
    Rush CR; Frey JM; Griffiths RR
    Psychopharmacology (Berl); 1999 Jul; 145(1):39-51. PubMed ID: 10445371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the acute behavioral effects of triazolam and temazepam in normal volunteers.
    Rush CR; Higgins ST; Hughes JR; Bickel WK
    Psychopharmacology (Berl); 1993; 112(4):407-14. PubMed ID: 7871050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated administration of diazepam and triazolam to subjects with histories of drug abuse.
    Roache JD; Griffiths RR
    Drug Alcohol Depend; 1986 May; 17(1):15-29. PubMed ID: 3720528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human progressive-ratio performance: maintenance by pentobarbital.
    McLeod DR; Griffiths RR
    Psychopharmacology (Berl); 1983; 79(1):4-9. PubMed ID: 6403962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of triazolam and ethanol on awareness, memory, and psychomotor performance.
    Roache JD; Cherek DR; Bennett RH; Schenkler JC; Cowan KA
    J Clin Psychopharmacol; 1993 Feb; 13(1):3-15. PubMed ID: 8486815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trazodone and triazolam: acute subject-rated and performance-impairing effects in healthy volunteers.
    Rush CR; Madakasira S; Hayes CA; Johnson CA; Goldman NH; Pazzaglia PJ
    Psychopharmacology (Berl); 1997 May; 131(1):9-18. PubMed ID: 9181630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans.
    Rush CR; Essman WD; Simpson CA; Baker RW
    J Clin Psychopharmacol; 2001 Jun; 21(3):273-86. PubMed ID: 11386490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory and sedative effects of triazolam in volunteers.
    Longbottom RT; Pleuvry BJ
    Br J Anaesth; 1984 Feb; 56(2):179-85. PubMed ID: 6140935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.
    Mumford GK; Rush CR; Griffiths RR
    J Pharmacol Exp Ther; 1995 Feb; 272(2):570-80. PubMed ID: 7853170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing single and cumulative dosing procedures in human triazolam discriminators.
    Smith BJ; Bickel WK
    J Exp Anal Behav; 1999 May; 71(3):417-37. PubMed ID: 10344022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abuse liability assessment of anxiolytics/hypnotics: rationale and laboratory lore.
    Evans SM; Critchfield TS; Griffiths RR
    Br J Addict; 1991 Dec; 86(12):1625-32. PubMed ID: 1686197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissociations in the expression of the sedative effects of triazolam.
    Weingartner HJ; Sirocco K; Rawlings R; Joyce E; Hommer D
    Psychopharmacology (Berl); 1995 May; 119(1):27-33. PubMed ID: 7675946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Individual differences in subjective responses to ethanol and triazolam.
    Holdstock L; de Wit H
    Behav Pharmacol; 1999 May; 10(3):283-95. PubMed ID: 10780243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychophysiological effects and dose equivalence of zopiclone and triazolam administered to healthy volunteers. Methodological considerations.
    Gorenstein C; Tavares SM; Gentil V; Peres C; Moreno RA; Dreyfus JF
    Braz J Med Biol Res; 1990; 23(10):941-51. PubMed ID: 2101059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the dependence-inducing potential of zopiclone and triazolam.
    Boissl K; Dreyfus JF; Delmotte M
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():242-7. PubMed ID: 6145680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triazolam impairs inhibitory control of behavior in humans.
    Fillmore MT; Rush CR; Kelly TH; Hays L
    Exp Clin Psychopharmacol; 2001 Nov; 9(4):363-71. PubMed ID: 11764012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons.
    Griffiths RR; Lamb RJ; Sannerud CA; Ator NA; Brady JV
    Psychopharmacology (Berl); 1991; 103(2):154-61. PubMed ID: 1674158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.